The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Chemokines, sTNF-Rs and sCD30 serum levels in healthy aged people and centenarians
Open accessAbstract
Several lines of evidence point to a profound remodelling of the cytokine network in healthy elderly subjects, with decreased type-1 cytokine production (IL 2) and a shift to type 0 and 2. We have also observed an increase of proinflammatory cytokines (IL-1, IL-6, TNF-alpha) in vitro, and an increase of circulating stem cell factor in vivo. In this setting, we studied changes of chemokines (MCP-1 and RANTES) with aging, as well as other molecules, namely, sTNF-RI and sTNF-RII, and the soluble form of the CD30 molecule (sCD30), involved in the pro- and antiinflammatory cytokine balance. The subjects enrolled in the study belonged to three different selected healthy groups of young, aged and centenarians. The presence of rheumatoid factor (RF) and antinuclear antibodies (ANA) was simultaneously assessed. The results show that MCP-1 serum levels were higher in the healthy aged and lowest in the young, while RANTES increased exclusively in centenarians. Only centenarians had autoantibodies (ANA and RF). sTNF-RI and sTNF-RII were significantly elevated in healthy old subjects compared to the young, and even higher in selected centenarians compared to the other age groups. sCD30 serum levels were significantly raised in centenarians compared to the young, despite absence of circulating CD30+ cells in the peripheral blood of the whole study population. No relationship among serum values of these different members of the TNF-R family was found, despite a strong correlation for sTNF-RI and sTNF-RII in all groups. We hypothesize that the increased chemokine levels in aged people, and raised sCD30 levels in centenarians, may reflect a general shift towards type 0/2 cytokines in normal aging, which may be responsible, at least in part, for the appearance of circulating autoantibodies without definite clinical consequences at advanced age.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Inflamm‐aging: An Evolutionary Perspective on Immunosenescence
FRANCESCHI, C., BONAFÈ, M., VALENSIN, S., OLIVIERI, F., DE LUCA, M., OTTAVIANI, E., & DE BENEDICTIS, G. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06651.x · Cited by 5,358
Self-citationNagata, S. (1997) · Cell · doi:10.1016/s0092-8674(00)81874-7 · Cited by 4,934
Thomson, A. W. (1994) · Cited by 1,114
Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1
Gu, L., Tseng, S., Horner, R. M., Tam‐Amersdorfer, C., Loda, M. F., & Rollins, B. J. (2000) · Nature · doi:10.1038/35006097 · Cited by 832
The chemokine system: redundancy for robust outputs
Mantovani, A. (1999) · Immunology Today · doi:10.1016/s0167-5699(99)01469-3 · Cited by 708
Self-citationIncreased cytokine production in mononuclear cells of healthy elderly people
Fagiolo, U., Cossarizza, A., Scala, E., Fanales‐Belasio, E., Ortolani, C., Cozzi, E., Monti, D., Franceschi, C., & Paganelli, R. (1993) · European Journal of Immunology · doi:10.1002/eji.1830230950 · Cited by 665
Self-citationThe immunology of exceptional individuals: the lesson of centenarians
Franceschi, C., Monti, D., Sansoni, P., & Cossarizza, A. (1995) · Immunology Today · doi:10.1016/0167-5699(95)80064-6 · Cited by 535
Self-citationFranceschi, C., Bonafè, M., & Valensin, S. (2000) · Vaccine · doi:10.1016/s0264-410x(99)00513-7 · Cited by 495
Self-citationPreferential expression of CD30 by human CD4 + T cells producing Th2‐type cytokines
Prete, G. D., Carli, M., Almerigogna, F., et al. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.1.7821763 · Cited by 366
Paganelli, R., Quinti, I., Fagiolo, U., Cossarizza, A., ORTOLANI, C., GUERRA, E., Sansoni, P., Pucillo, L. P., Scala, E., Cozzi, E., et al. (1992) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1992.tb07954.x · Cited by 156
Self-citationCossarizza, A., Ortolani, C., Forti, E., Montagnani, G., Paganelli, R., Zannotti, M., Marini, M., Monti, D., & Franceschi, C. (1991) · Blood · doi:10.1182/blood.v77.6.1263.1263 · Cited by 114
Self-citationCaligaris‐Cappio, F., Bertero, M., Converso, M., et al. (1995) · PubMed · Cited by 110
In vivo CD30 expression in human diseases with predominant activation of Th2-like T cells
D’Elios, M. M., Romagnani, P., Scaletti, C., Annunziato, F., Manghetti, M., Mavilia, C., Parronchi, P., Pupilli, C., Pizzolo, G., Maggi, E., et al. (1997) · Journal of Leukocyte Biology · doi:10.1002/jlb.61.5.539 · Cited by 106
Bagnara, G. P., Bonsi, L., Strippoli, P., Bonifazi, F., Tonelli, R., D’Addato, S., Paganelli, R., Scala, E., Fagiolo, U., Monti, D., et al. (2000) · The Journals of Gerontology Series A · doi:10.1093/gerona/55.2.b61 · Cited by 100
Self-citationRole of CD30+ T cells in rheumatoid arthritis: a counter-regulatory paradigm for Th1-driven diseases
Gerli, R., Lunardi, C., Vinante, F., Bistoni, O., Pizzolo, G., & Pitzalis, C. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(00)01829-9 · Cited by 79
Self-citationGerli, R., Muscat, C., Bistoni, O., et al. (1995) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1995.tb03851.x · Cited by 77
Self-citationCD30+ T Cells in Rheumatoid Synovitis: Mechanisms of Recruitment and Functional Role
Gerli, R., Pitzalis, C., Bistoni, O., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.8.4399 · Cited by 76
Self-citationGiacomelli, R., Cipriani, P., LATTANZIO, R., et al. (1997) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1997.d01-991.x · Cited by 65
Krampera, M., Vinante, F., Tavecchia, L., Morosato, L., Chilosi, M., Romagnani, S., Zanolin, M. E., & Pizzolo, G. (1999) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.1999.00977.x · Cited by 60
Peri, G., Milanese, C., Matteucci, C., et al. (1994) · Journal of Immunological Methods · doi:10.1016/0022-1759(94)90029-9 · Cited by 57
Self-citationPaganelli, R., Scala, E., Rosso, R., Cossarizza, A., Bertollo, L., Barbieri, D., Fabrizi, A., Lusi, E. A., Fagiolo, U., & Franceschi, C. (1996) · European Journal of Immunology · doi:10.1002/eji.1830260910 · Cited by 50
Self-citationScala, E., Carbonari, M., Porto, P. D., Cibati, M., Tedesco, T., MAZZONE, A. M., Paganelli, R., & Fiorilli, M. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.1.489 · Cited by 34
Self-citationScala, E., Carbonari, M., Porto, P. D., et al. (1998) · PubMed · Cited by 32
Pawelec, G., Mariani, E., Bradley, B., & Solana, R. (2000) · Biogerontology · doi:10.1023/a:1010086229931 · Cited by 25
Soluble CD30 in primary Sjögren's syndrome.
Gerli, R., Caligaris‐Cappio, F., Bistoni, O., et al. (1999) · PubMed · Cited by 14
Self-citationTelford, W. G., & Miller, R. A. (1999) · Cellular Immunology · doi:10.1006/cimm.1998.1422 · Cited by 13
Circulating soluble CD30 levels in primary Sjögren's syndrome, SLE and rheumatoid arthritis.
Ichikawa, Y., Yoshida, M., Yamada, C., et al. (1999) · PubMed · Cited by 12
Flagged first, then by citations
Research works printed but not linked: 1
- Gerli, 1999, Solubile CD30 in primary Sjogren's sindrome, Clin. Exp. Rheumatol., 17, 389
Cited by
Sorted by citations
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
Ferrucci, L., & Fabbri, E. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0064-2 · Cited by 3,690
Proinflammatory Cytokines, Aging, and Age-Related Diseases
Michaud, M., Balardy, L., Moulis, G., Gaudin, C., Peyrot, C., Vellas, B., Cesari, M., & Nourhashemi, F. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.009 · Cited by 1,094
Franceschi, C., Garagnani, P., Vitale, G., Capri, M., & Salvioli, S. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.09.005 · Cited by 997
Self-citationInflammatory mediators in the elderly
Krabbe, K. S., Pedersen, M., & Bruunsgaard, H. (2004) · Experimental Gerontology · doi:10.1016/j.exger.2004.01.009 · Cited by 928
Immunosenescence and inflammaging in the aging process: age-related diseases or longevity?
Santoro, A., Bientinesi, E., & Monti, D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101422 · Cited by 603
Self-citationA Consideration of Biomarkers to be Used for Evaluation of Inflammation in Human Nutritional Studies
Calder, P. C., Ahluwalia, N., Albers, R., Bosco, N., Bourdet-Sicard, R., Haller, D., Holgate, S. T., Jönsson, L. S., Latulippe, M. E., Marcos, A., et al. (2013) · British Journal of Nutrition · doi:10.1017/s0007114512005119 · Cited by 425
Effects of ageing on the immune system: Infants to elderly
Valiathan, R., Ashman, M., & Asthana, D. (2016) · Scandinavian Journal of Immunology · doi:10.1111/sji.12413 · Cited by 380
Franceschi, C., Salvioli, S., Garagnani, P., de Eguileor, M., Monti, D., & Capri, M. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00982 · Cited by 290
Self-citationVescovini, R., Biasini, C., Fagnoni, F. F., Telera, A. R., Zanlari, L., Pedrazzoni, M., Bucci, L., Monti, D., Medici, M. C., Chezzi, C., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.6.4283 · Cited by 173
Self-citationVitale, G., Pellegrino, G., Vollery, M., & Hofland, L. J. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00027 · Cited by 166
Nasi, M., Troiano, L., Lugli, E., Pinti, M., Ferraresi, R., Monterastelli, E., Mussi, C., Salvioli, G., Franceschi, C., & Cossarizza, A. (2006) · Aging Cell · doi:10.1111/j.1474-9726.2006.00204.x · Cited by 127
Self-citationLong-Term Physical Activity and Inflammatory Biomarkers in Older Adults
BEAVERS, K. M., HSU, F.-C., ISOM, S., KRITCHEVSKY, S. B., CHURCH, T., GOODPASTER, B., PAHOR, M., & NICKLAS, B. J. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181e3ac80 · Cited by 108
Dynamic alteration of soluble serum biomarkers in healthy aging
Shurin, G. V., Yurkovetsky, Z. R., Chatta, G. S., Tourkova, I. L., Shurin, M. R., & Lokshin, A. E. (2007) · Cytokine · doi:10.1016/j.cyto.2007.06.006 · Cited by 95
Vascular Inflammation in Aging
Ungvari, Z., Csiszar, A., & Kaley, G. (2004) · Herz · doi:10.1007/s00059-004-2625-x · Cited by 75
Increased Soluble TNF Receptor 2 in Antidepressant-Free Patients with Late-Life Depression
Diniz, B. S., Teixeira, A. L., Talib, L. L., Mendonça, V. A., Gattaz, W. F., & Forlenza, O. V. (2010) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2010.02.008 · Cited by 54
Metadata
- Authors
- Gerli, R., Monti, D., Bistoni, O., M. Mazzone, A., Peri, G., Cossarizza, A., Di Gioacchino, M., E. F. Cesarotti, M., Doni, A., Mantovani, A., Franceschi, C., & Paganelli, R.
- Affiliations
- University of Perugia (IT)
- University of Florence (IT)
- Mario Negri Institute for Pharmacological Research (IT)
- University of Modena and Reggio Emilia (IT)
- Istituto Nazionale di Riposo e Cura per Anziani (IT)
- University of Chieti-Pescara (IT)
- Corresponding author
- Paganelli, Roberto
- ORCID
- Venue
- Mechanisms of Ageing and Development
- Publisher
- Elsevier BV
- Published
- 2001-01
- Volume
- 121
- Issue
- 1-3
- Pages
- 37-46
- ISSN
- 0047-6374 (ISSN-L)
- OpenAlex
- W2030493262
- Cited by
- 162
- References
- 27
- Citations by year
- 2026: 1 · 2025: 7 · 2024: 7 · 2023: 5 · 2022: 8 · 2021: 8 · 2020: 9 · 2019: 11 · 2018: 7 · 2017: 7 · 2016: 9 · 2015: 3 · 2014: 2 · 2013: 8 · 2012: 7
- FWCI
- 2.21
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- Locations
- Mechanisms of Ageing and Development (publishedVersion)
- PubMed (publishedVersion)
- Florence Research (University of Florence) (submittedVersion)
- IRIS UNIMORE (University of Modena and Reggio Emilia) (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Keywords
- chemokines, soluble TNF receptors, soluble CD30, centenarians, healthy aging, MCP-1, RANTES, autoantibodies, rheumatoid factor, antinuclear antibodies, inflammatory cytokines
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, Antibodies, Antinuclear, Humans, Reference Values, Rheumatoid Factor, Solubility, Ki-1 Antigen, Receptors, Tumor Necrosis Factor, Chemokines, Chemokine CCL2, Chemokine CCL5
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review